Global Nuclear Medicine Market Research Report 2024(Status and Outlook)
Report Overview:
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The Global Nuclear Medicine Market Size was estimated at USD 4041.29 million in 2023 and is projected to reach USD 6202.20 million by 2029, exhibiting a CAGR of 7.40% during the forecast period.
This report provides a deep insight into the global Nuclear Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine market in any manner.
Global Nuclear Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Nuclear Medicine?or Radiopharmaceuticals? are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
The Global Nuclear Medicine Market Size was estimated at USD 4041.29 million in 2023 and is projected to reach USD 6202.20 million by 2029, exhibiting a CAGR of 7.40% during the forecast period.
This report provides a deep insight into the global Nuclear Medicine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nuclear Medicine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nuclear Medicine market in any manner.
Global Nuclear Medicine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Market Segmentation (by Application)
Diagnostic
Therapeutic
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Nuclear Medicine Market
- Overview of the regional outlook of the Nuclear Medicine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nuclear Medicine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nuclear Medicine
1.2 Key Market Segments
1.2.1 Nuclear Medicine Segment by Type
1.2.2 Nuclear Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Medicine Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Price by Type (2019-2024)
7 NUCLEAR MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
8 NUCLEAR MEDICINE MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Medicine Sales by Region
8.1.1 Global Nuclear Medicine Sales by Region
8.1.2 Global Nuclear Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GE Healthcare
9.1.1 GE Healthcare Nuclear Medicine Basic Information
9.1.2 GE Healthcare Nuclear Medicine Product Overview
9.1.3 GE Healthcare Nuclear Medicine Product Market Performance
9.1.4 GE Healthcare Business Overview
9.1.5 GE Healthcare Nuclear Medicine SWOT Analysis
9.1.6 GE Healthcare Recent Developments
9.2 Bracco Imaging
9.2.1 Bracco Imaging Nuclear Medicine Basic Information
9.2.2 Bracco Imaging Nuclear Medicine Product Overview
9.2.3 Bracco Imaging Nuclear Medicine Product Market Performance
9.2.4 Bracco Imaging Business Overview
9.2.5 Bracco Imaging Nuclear Medicine SWOT Analysis
9.2.6 Bracco Imaging Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Nuclear Medicine Basic Information
9.3.2 Mallinckrodt Nuclear Medicine Product Overview
9.3.3 Mallinckrodt Nuclear Medicine Product Market Performance
9.3.4 Mallinckrodt Nuclear Medicine SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Lantheus Medical Imaging
9.4.1 Lantheus Medical Imaging Nuclear Medicine Basic Information
9.4.2 Lantheus Medical Imaging Nuclear Medicine Product Overview
9.4.3 Lantheus Medical Imaging Nuclear Medicine Product Market Performance
9.4.4 Lantheus Medical Imaging Business Overview
9.4.5 Lantheus Medical Imaging Recent Developments
9.5 Bayer
9.5.1 Bayer Nuclear Medicine Basic Information
9.5.2 Bayer Nuclear Medicine Product Overview
9.5.3 Bayer Nuclear Medicine Product Market Performance
9.5.4 Bayer Business Overview
9.5.5 Bayer Recent Developments
9.6 Triad Isotopes
9.6.1 Triad Isotopes Nuclear Medicine Basic Information
9.6.2 Triad Isotopes Nuclear Medicine Product Overview
9.6.3 Triad Isotopes Nuclear Medicine Product Market Performance
9.6.4 Triad Isotopes Business Overview
9.6.5 Triad Isotopes Recent Developments
9.7 Nordion
9.7.1 Nordion Nuclear Medicine Basic Information
9.7.2 Nordion Nuclear Medicine Product Overview
9.7.3 Nordion Nuclear Medicine Product Market Performance
9.7.4 Nordion Business Overview
9.7.5 Nordion Recent Developments
9.8 Jubilant Pharma
9.8.1 Jubilant Pharma Nuclear Medicine Basic Information
9.8.2 Jubilant Pharma Nuclear Medicine Product Overview
9.8.3 Jubilant Pharma Nuclear Medicine Product Market Performance
9.8.4 Jubilant Pharma Business Overview
9.8.5 Jubilant Pharma Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Nuclear Medicine Basic Information
9.9.2 Eli Lilly Nuclear Medicine Product Overview
9.9.3 Eli Lilly Nuclear Medicine Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 SIEMENS
9.10.1 SIEMENS Nuclear Medicine Basic Information
9.10.2 SIEMENS Nuclear Medicine Product Overview
9.10.3 SIEMENS Nuclear Medicine Product Market Performance
9.10.4 SIEMENS Business Overview
9.10.5 SIEMENS Recent Developments
9.11 China Isotope and Radiation
9.11.1 China Isotope and Radiation Nuclear Medicine Basic Information
9.11.2 China Isotope and Radiation Nuclear Medicine Product Overview
9.11.3 China Isotope and Radiation Nuclear Medicine Product Market Performance
9.11.4 China Isotope and Radiation Business Overview
9.11.5 China Isotope and Radiation Recent Developments
9.12 Dongcheng
9.12.1 Dongcheng Nuclear Medicine Basic Information
9.12.2 Dongcheng Nuclear Medicine Product Overview
9.12.3 Dongcheng Nuclear Medicine Product Market Performance
9.12.4 Dongcheng Business Overview
9.12.5 Dongcheng Recent Developments
10 NUCLEAR MEDICINE MARKET FORECAST BY REGION
10.1 Global Nuclear Medicine Market Size Forecast
10.2 Global Nuclear Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine by Type (2025-2030)
11.1.2 Global Nuclear Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine by Type (2025-2030)
11.2 Global Nuclear Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nuclear Medicine
1.2 Key Market Segments
1.2.1 Nuclear Medicine Segment by Type
1.2.2 Nuclear Medicine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NUCLEAR MEDICINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nuclear Medicine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nuclear Medicine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NUCLEAR MEDICINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Nuclear Medicine Sales by Manufacturers (2019-2024)
3.2 Global Nuclear Medicine Revenue Market Share by Manufacturers (2019-2024)
3.3 Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nuclear Medicine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nuclear Medicine Sales Sites, Area Served, Product Type
3.6 Nuclear Medicine Market Competitive Situation and Trends
3.6.1 Nuclear Medicine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nuclear Medicine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 NUCLEAR MEDICINE INDUSTRY CHAIN ANALYSIS
4.1 Nuclear Medicine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NUCLEAR MEDICINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 NUCLEAR MEDICINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nuclear Medicine Sales Market Share by Type (2019-2024)
6.3 Global Nuclear Medicine Market Size Market Share by Type (2019-2024)
6.4 Global Nuclear Medicine Price by Type (2019-2024)
7 NUCLEAR MEDICINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nuclear Medicine Market Sales by Application (2019-2024)
7.3 Global Nuclear Medicine Market Size (M USD) by Application (2019-2024)
7.4 Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
8 NUCLEAR MEDICINE MARKET SEGMENTATION BY REGION
8.1 Global Nuclear Medicine Sales by Region
8.1.1 Global Nuclear Medicine Sales by Region
8.1.2 Global Nuclear Medicine Sales Market Share by Region
8.2 North America
8.2.1 North America Nuclear Medicine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nuclear Medicine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nuclear Medicine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nuclear Medicine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nuclear Medicine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GE Healthcare
9.1.1 GE Healthcare Nuclear Medicine Basic Information
9.1.2 GE Healthcare Nuclear Medicine Product Overview
9.1.3 GE Healthcare Nuclear Medicine Product Market Performance
9.1.4 GE Healthcare Business Overview
9.1.5 GE Healthcare Nuclear Medicine SWOT Analysis
9.1.6 GE Healthcare Recent Developments
9.2 Bracco Imaging
9.2.1 Bracco Imaging Nuclear Medicine Basic Information
9.2.2 Bracco Imaging Nuclear Medicine Product Overview
9.2.3 Bracco Imaging Nuclear Medicine Product Market Performance
9.2.4 Bracco Imaging Business Overview
9.2.5 Bracco Imaging Nuclear Medicine SWOT Analysis
9.2.6 Bracco Imaging Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Nuclear Medicine Basic Information
9.3.2 Mallinckrodt Nuclear Medicine Product Overview
9.3.3 Mallinckrodt Nuclear Medicine Product Market Performance
9.3.4 Mallinckrodt Nuclear Medicine SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Lantheus Medical Imaging
9.4.1 Lantheus Medical Imaging Nuclear Medicine Basic Information
9.4.2 Lantheus Medical Imaging Nuclear Medicine Product Overview
9.4.3 Lantheus Medical Imaging Nuclear Medicine Product Market Performance
9.4.4 Lantheus Medical Imaging Business Overview
9.4.5 Lantheus Medical Imaging Recent Developments
9.5 Bayer
9.5.1 Bayer Nuclear Medicine Basic Information
9.5.2 Bayer Nuclear Medicine Product Overview
9.5.3 Bayer Nuclear Medicine Product Market Performance
9.5.4 Bayer Business Overview
9.5.5 Bayer Recent Developments
9.6 Triad Isotopes
9.6.1 Triad Isotopes Nuclear Medicine Basic Information
9.6.2 Triad Isotopes Nuclear Medicine Product Overview
9.6.3 Triad Isotopes Nuclear Medicine Product Market Performance
9.6.4 Triad Isotopes Business Overview
9.6.5 Triad Isotopes Recent Developments
9.7 Nordion
9.7.1 Nordion Nuclear Medicine Basic Information
9.7.2 Nordion Nuclear Medicine Product Overview
9.7.3 Nordion Nuclear Medicine Product Market Performance
9.7.4 Nordion Business Overview
9.7.5 Nordion Recent Developments
9.8 Jubilant Pharma
9.8.1 Jubilant Pharma Nuclear Medicine Basic Information
9.8.2 Jubilant Pharma Nuclear Medicine Product Overview
9.8.3 Jubilant Pharma Nuclear Medicine Product Market Performance
9.8.4 Jubilant Pharma Business Overview
9.8.5 Jubilant Pharma Recent Developments
9.9 Eli Lilly
9.9.1 Eli Lilly Nuclear Medicine Basic Information
9.9.2 Eli Lilly Nuclear Medicine Product Overview
9.9.3 Eli Lilly Nuclear Medicine Product Market Performance
9.9.4 Eli Lilly Business Overview
9.9.5 Eli Lilly Recent Developments
9.10 SIEMENS
9.10.1 SIEMENS Nuclear Medicine Basic Information
9.10.2 SIEMENS Nuclear Medicine Product Overview
9.10.3 SIEMENS Nuclear Medicine Product Market Performance
9.10.4 SIEMENS Business Overview
9.10.5 SIEMENS Recent Developments
9.11 China Isotope and Radiation
9.11.1 China Isotope and Radiation Nuclear Medicine Basic Information
9.11.2 China Isotope and Radiation Nuclear Medicine Product Overview
9.11.3 China Isotope and Radiation Nuclear Medicine Product Market Performance
9.11.4 China Isotope and Radiation Business Overview
9.11.5 China Isotope and Radiation Recent Developments
9.12 Dongcheng
9.12.1 Dongcheng Nuclear Medicine Basic Information
9.12.2 Dongcheng Nuclear Medicine Product Overview
9.12.3 Dongcheng Nuclear Medicine Product Market Performance
9.12.4 Dongcheng Business Overview
9.12.5 Dongcheng Recent Developments
10 NUCLEAR MEDICINE MARKET FORECAST BY REGION
10.1 Global Nuclear Medicine Market Size Forecast
10.2 Global Nuclear Medicine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nuclear Medicine Market Size Forecast by Country
10.2.3 Asia Pacific Nuclear Medicine Market Size Forecast by Region
10.2.4 South America Nuclear Medicine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nuclear Medicine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Nuclear Medicine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nuclear Medicine by Type (2025-2030)
11.1.2 Global Nuclear Medicine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nuclear Medicine by Type (2025-2030)
11.2 Global Nuclear Medicine Market Forecast by Application (2025-2030)
11.2.1 Global Nuclear Medicine Sales (K Units) Forecast by Application
11.2.2 Global Nuclear Medicine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Nuclear Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2022)
Table 10. Global Market Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Medicine Sales Sites and Area Served
Table 12. Manufacturers Nuclear Medicine Product Type
Table 13. Global Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine Market Challenges
Table 22. Global Nuclear Medicine Sales by Type (K Units)
Table 23. Global Nuclear Medicine Market Size by Type (M USD)
Table 24. Global Nuclear Medicine Sales (K Units) by Type (2019-2024)
Table 25. Global Nuclear Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Medicine Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Medicine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Nuclear Medicine Sales (K Units) by Application
Table 30. Global Nuclear Medicine Market Size by Application
Table 31. Global Nuclear Medicine Sales by Application (2019-2024) & (K Units)
Table 32. Global Nuclear Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Medicine Market Share by Application (2019-2024)
Table 35. Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 37. Global Nuclear Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 41. South America Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 43. GE Healthcare Nuclear Medicine Basic Information
Table 44. GE Healthcare Nuclear Medicine Product Overview
Table 45. GE Healthcare Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Nuclear Medicine SWOT Analysis
Table 48. GE Healthcare Recent Developments
Table 49. Bracco Imaging Nuclear Medicine Basic Information
Table 50. Bracco Imaging Nuclear Medicine Product Overview
Table 51. Bracco Imaging Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bracco Imaging Business Overview
Table 53. Bracco Imaging Nuclear Medicine SWOT Analysis
Table 54. Bracco Imaging Recent Developments
Table 55. Mallinckrodt Nuclear Medicine Basic Information
Table 56. Mallinckrodt Nuclear Medicine Product Overview
Table 57. Mallinckrodt Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Nuclear Medicine SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Lantheus Medical Imaging Nuclear Medicine Basic Information
Table 62. Lantheus Medical Imaging Nuclear Medicine Product Overview
Table 63. Lantheus Medical Imaging Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lantheus Medical Imaging Business Overview
Table 65. Lantheus Medical Imaging Recent Developments
Table 66. Bayer Nuclear Medicine Basic Information
Table 67. Bayer Nuclear Medicine Product Overview
Table 68. Bayer Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Business Overview
Table 70. Bayer Recent Developments
Table 71. Triad Isotopes Nuclear Medicine Basic Information
Table 72. Triad Isotopes Nuclear Medicine Product Overview
Table 73. Triad Isotopes Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Triad Isotopes Business Overview
Table 75. Triad Isotopes Recent Developments
Table 76. Nordion Nuclear Medicine Basic Information
Table 77. Nordion Nuclear Medicine Product Overview
Table 78. Nordion Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Nordion Business Overview
Table 80. Nordion Recent Developments
Table 81. Jubilant Pharma Nuclear Medicine Basic Information
Table 82. Jubilant Pharma Nuclear Medicine Product Overview
Table 83. Jubilant Pharma Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Jubilant Pharma Business Overview
Table 85. Jubilant Pharma Recent Developments
Table 86. Eli Lilly Nuclear Medicine Basic Information
Table 87. Eli Lilly Nuclear Medicine Product Overview
Table 88. Eli Lilly Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. SIEMENS Nuclear Medicine Basic Information
Table 92. SIEMENS Nuclear Medicine Product Overview
Table 93. SIEMENS Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SIEMENS Business Overview
Table 95. SIEMENS Recent Developments
Table 96. China Isotope and Radiation Nuclear Medicine Basic Information
Table 97. China Isotope and Radiation Nuclear Medicine Product Overview
Table 98. China Isotope and Radiation Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. China Isotope and Radiation Business Overview
Table 100. China Isotope and Radiation Recent Developments
Table 101. Dongcheng Nuclear Medicine Basic Information
Table 102. Dongcheng Nuclear Medicine Product Overview
Table 103. Dongcheng Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Dongcheng Business Overview
Table 105. Dongcheng Recent Developments
Table 106. Global Nuclear Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Nuclear Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Nuclear Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Nuclear Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Nuclear Medicine Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Nuclear Medicine Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Nuclear Medicine Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Nuclear Medicine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Nuclear Medicine Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Nuclear Medicine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nuclear Medicine Market Size Comparison by Region (M USD)
Table 5. Global Nuclear Medicine Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Nuclear Medicine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nuclear Medicine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nuclear Medicine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2022)
Table 10. Global Market Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nuclear Medicine Sales Sites and Area Served
Table 12. Manufacturers Nuclear Medicine Product Type
Table 13. Global Nuclear Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nuclear Medicine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nuclear Medicine Market Challenges
Table 22. Global Nuclear Medicine Sales by Type (K Units)
Table 23. Global Nuclear Medicine Market Size by Type (M USD)
Table 24. Global Nuclear Medicine Sales (K Units) by Type (2019-2024)
Table 25. Global Nuclear Medicine Sales Market Share by Type (2019-2024)
Table 26. Global Nuclear Medicine Market Size (M USD) by Type (2019-2024)
Table 27. Global Nuclear Medicine Market Size Share by Type (2019-2024)
Table 28. Global Nuclear Medicine Price (USD/Unit) by Type (2019-2024)
Table 29. Global Nuclear Medicine Sales (K Units) by Application
Table 30. Global Nuclear Medicine Market Size by Application
Table 31. Global Nuclear Medicine Sales by Application (2019-2024) & (K Units)
Table 32. Global Nuclear Medicine Sales Market Share by Application (2019-2024)
Table 33. Global Nuclear Medicine Sales by Application (2019-2024) & (M USD)
Table 34. Global Nuclear Medicine Market Share by Application (2019-2024)
Table 35. Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
Table 36. Global Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 37. Global Nuclear Medicine Sales Market Share by Region (2019-2024)
Table 38. North America Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 39. Europe Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 41. South America Nuclear Medicine Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Nuclear Medicine Sales by Region (2019-2024) & (K Units)
Table 43. GE Healthcare Nuclear Medicine Basic Information
Table 44. GE Healthcare Nuclear Medicine Product Overview
Table 45. GE Healthcare Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. GE Healthcare Business Overview
Table 47. GE Healthcare Nuclear Medicine SWOT Analysis
Table 48. GE Healthcare Recent Developments
Table 49. Bracco Imaging Nuclear Medicine Basic Information
Table 50. Bracco Imaging Nuclear Medicine Product Overview
Table 51. Bracco Imaging Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Bracco Imaging Business Overview
Table 53. Bracco Imaging Nuclear Medicine SWOT Analysis
Table 54. Bracco Imaging Recent Developments
Table 55. Mallinckrodt Nuclear Medicine Basic Information
Table 56. Mallinckrodt Nuclear Medicine Product Overview
Table 57. Mallinckrodt Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Nuclear Medicine SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Lantheus Medical Imaging Nuclear Medicine Basic Information
Table 62. Lantheus Medical Imaging Nuclear Medicine Product Overview
Table 63. Lantheus Medical Imaging Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Lantheus Medical Imaging Business Overview
Table 65. Lantheus Medical Imaging Recent Developments
Table 66. Bayer Nuclear Medicine Basic Information
Table 67. Bayer Nuclear Medicine Product Overview
Table 68. Bayer Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Bayer Business Overview
Table 70. Bayer Recent Developments
Table 71. Triad Isotopes Nuclear Medicine Basic Information
Table 72. Triad Isotopes Nuclear Medicine Product Overview
Table 73. Triad Isotopes Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Triad Isotopes Business Overview
Table 75. Triad Isotopes Recent Developments
Table 76. Nordion Nuclear Medicine Basic Information
Table 77. Nordion Nuclear Medicine Product Overview
Table 78. Nordion Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Nordion Business Overview
Table 80. Nordion Recent Developments
Table 81. Jubilant Pharma Nuclear Medicine Basic Information
Table 82. Jubilant Pharma Nuclear Medicine Product Overview
Table 83. Jubilant Pharma Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Jubilant Pharma Business Overview
Table 85. Jubilant Pharma Recent Developments
Table 86. Eli Lilly Nuclear Medicine Basic Information
Table 87. Eli Lilly Nuclear Medicine Product Overview
Table 88. Eli Lilly Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Eli Lilly Business Overview
Table 90. Eli Lilly Recent Developments
Table 91. SIEMENS Nuclear Medicine Basic Information
Table 92. SIEMENS Nuclear Medicine Product Overview
Table 93. SIEMENS Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. SIEMENS Business Overview
Table 95. SIEMENS Recent Developments
Table 96. China Isotope and Radiation Nuclear Medicine Basic Information
Table 97. China Isotope and Radiation Nuclear Medicine Product Overview
Table 98. China Isotope and Radiation Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. China Isotope and Radiation Business Overview
Table 100. China Isotope and Radiation Recent Developments
Table 101. Dongcheng Nuclear Medicine Basic Information
Table 102. Dongcheng Nuclear Medicine Product Overview
Table 103. Dongcheng Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Dongcheng Business Overview
Table 105. Dongcheng Recent Developments
Table 106. Global Nuclear Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 107. Global Nuclear Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 109. North America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 111. Europe Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Nuclear Medicine Sales Forecast by Region (2025-2030) & (K Units)
Table 113. Asia Pacific Nuclear Medicine Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Nuclear Medicine Sales Forecast by Country (2025-2030) & (K Units)
Table 115. South America Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Nuclear Medicine Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Nuclear Medicine Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Nuclear Medicine Sales Forecast by Type (2025-2030) & (K Units)
Table 119. Global Nuclear Medicine Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Nuclear Medicine Price Forecast by Type (2025-2030) & (USD/Unit)
Table 121. Global Nuclear Medicine Sales (K Units) Forecast by Application (2025-2030)
Table 122. Global Nuclear Medicine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nuclear Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Medicine Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Medicine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Market Size by Country (M USD)
Figure 11. Nuclear Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Medicine Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Medicine Market Share by Type
Figure 18. Sales Market Share of Nuclear Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Medicine by Type in 2023
Figure 20. Market Size Share of Nuclear Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Medicine Market Share by Application
Figure 24. Global Nuclear Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Medicine Sales Market Share by Application in 2023
Figure 26. Global Nuclear Medicine Market Share by Application (2019-2024)
Figure 27. Global Nuclear Medicine Market Share by Application in 2023
Figure 28. Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Nuclear Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Nuclear Medicine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Nuclear Medicine Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Nuclear Medicine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nuclear Medicine Sales Market Share by Region in 2023
Figure 44. China Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Nuclear Medicine Sales and Growth Rate (K Units)
Figure 50. South America Nuclear Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Nuclear Medicine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nuclear Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Nuclear Medicine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Nuclear Medicine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Medicine Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Medicine Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Medicine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Nuclear Medicine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nuclear Medicine Market Size (M USD), 2019-2030
Figure 5. Global Nuclear Medicine Market Size (M USD) (2019-2030)
Figure 6. Global Nuclear Medicine Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nuclear Medicine Market Size by Country (M USD)
Figure 11. Nuclear Medicine Sales Share by Manufacturers in 2023
Figure 12. Global Nuclear Medicine Revenue Share by Manufacturers in 2023
Figure 13. Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nuclear Medicine Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nuclear Medicine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nuclear Medicine Market Share by Type
Figure 18. Sales Market Share of Nuclear Medicine by Type (2019-2024)
Figure 19. Sales Market Share of Nuclear Medicine by Type in 2023
Figure 20. Market Size Share of Nuclear Medicine by Type (2019-2024)
Figure 21. Market Size Market Share of Nuclear Medicine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nuclear Medicine Market Share by Application
Figure 24. Global Nuclear Medicine Sales Market Share by Application (2019-2024)
Figure 25. Global Nuclear Medicine Sales Market Share by Application in 2023
Figure 26. Global Nuclear Medicine Market Share by Application (2019-2024)
Figure 27. Global Nuclear Medicine Market Share by Application in 2023
Figure 28. Global Nuclear Medicine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nuclear Medicine Sales Market Share by Region (2019-2024)
Figure 30. North America Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Nuclear Medicine Sales Market Share by Country in 2023
Figure 32. U.S. Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Nuclear Medicine Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Nuclear Medicine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Nuclear Medicine Sales Market Share by Country in 2023
Figure 37. Germany Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Nuclear Medicine Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Nuclear Medicine Sales Market Share by Region in 2023
Figure 44. China Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Nuclear Medicine Sales and Growth Rate (K Units)
Figure 50. South America Nuclear Medicine Sales Market Share by Country in 2023
Figure 51. Brazil Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Nuclear Medicine Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Nuclear Medicine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Nuclear Medicine Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Nuclear Medicine Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Nuclear Medicine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nuclear Medicine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nuclear Medicine Market Share Forecast by Type (2025-2030)
Figure 65. Global Nuclear Medicine Sales Forecast by Application (2025-2030)
Figure 66. Global Nuclear Medicine Market Share Forecast by Application (2025-2030)
